Holen Sie sich die Stockscreener-App
2.32
0.43%
-0.01
Schlusskurs vom Vortag:
$2.33
Offen:
$2.35
24-Stunden-Volumen:
57,227
Relative Volume:
0.24
Marktkapitalisierung:
$61.92M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-1.4803
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
-3.73%
1M Leistung:
-24.18%
6M Leistung:
+47.77%
1J Leistung:
-15.94%
1-Tages-Spanne:
$2.25
$2.3894
1-Wochen-Bereich:
$2.02
$2.5258
52-Wochen-Spanne:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Vergleichen Sie CELU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
2.32 | 62.72M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Celularity (NASDAQ:CELU) Upgraded by WBB Securities to Buy Rating - MarketBeat
Celularity Inc. Equity Warrant stock trend outlook and recovery pathMarket Sentiment Report & Entry Point Confirmation Alerts - Newser
Is it too late to sell Celularity Inc. Equity Warrant2025 Market Overview & Fast Moving Stock Watchlists - Newser
Celularity stock rating upgraded to Buy by WBB Securities on CMS reimbursement changes - Investing.com
WBB Securities Maintains Celularity(CELU.US) With Buy Rating, Maintains Target Price $6 - 富途牛牛
Will Celularity Inc. Equity Warrant price bounce be sustainableJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - Newser
Traders Watching For Reversal Pattern in Celularity Inc. Equity WarrantWeekly Risk Summary & Technical Entry and Exit Tips - 뉴스영
Price Clustering Detected in Celularity Inc. StockQuarterly Profit Report & Safe Capital Growth Stock Tips - beatles.ru
Quant Models Detect Momentum Reversal in Celularity Inc. Equity Warrant2025 Geopolitical Influence & Precise Entry and Exit Recommendations - beatles.ru
What is Celularity Inc. Equity Warrant’s book value per shareRecession Risk & Risk Managed Investment Strategies - beatles.ru
Is Celularity Inc. stock a good dividend stockJuly 2025 Update & Long-Term Safe Investment Ideas - classian.co.kr
Published on: 2025-09-06 13:52:18 - Newser
Risk vs reward if holding onto Celularity Inc. Equity Warrant2025 Performance Recap & Accurate Entry and Exit Point Alerts - Newser
Celularity Inc. stock trend forecast2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Key resistance and support levels for Celularity Inc. Equity WarrantWeekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
Understanding Celularity Inc.’s price movement2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser
Using Ichimoku Cloud for Celularity Inc. Equity Warrant technicalsAnalyst Downgrade & Verified Momentum Stock Ideas - Newser
What is Celularity Inc.’s TAM (Total Addressable Market)Earnings Performance Report & Fast Exit Strategy with Risk Control - خودرو بانک
Is Celularity Inc. being accumulated by smart moneyRate Hike & Long-Term Capital Growth Ideas - خودرو بانک
What is the earnings history of Celularity Inc. Equity WarrantRisk Management & Long Hold Capital Preservation Plans - خودرو بانک
What makes Celularity Inc. Equity Warrant stock price move sharplyExit Point & Long Hold Capital Preservation Plans - Newser
Can Celularity Inc. continue delivering strong returnsMarket Sentiment Report & Real-Time Volume Spike Alerts - خودرو بانک
Should I buy Celularity Inc. stock now2025 Price Targets & Weekly Sector Rotation Insights - خودرو بانک
Long term hold vs stop loss in Celularity Inc. Equity WarrantJuly 2025 Macro Moves & Weekly High Return Opportunities - Newser
Can Celularity Inc. Equity Warrant hit a new high this month2025 Market Outlook & Risk Managed Investment Signals - Newser
Will Celularity Inc. stock recover after earningsJuly 2025 Earnings & Accurate Intraday Trading Signals - خودرو بانک
Celularity Inc. Stock Performance After Earnings: Historical Insights2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
Is Celularity Inc. reversing from oversold territory2025 Valuation Update & Community Supported Trade Ideas - Newser
What moving averages say about Celularity Inc. Equity WarrantPortfolio Performance Summary & Expert Verified Movement Alerts - Newser
Applying Wyckoff theory to Celularity Inc. stockWeekly Trade Review & Long-Term Safe Investment Plans - Newser
What earnings revisions data tells us about Celularity Inc. Equity WarrantWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
What institutional flow reveals about Celularity Inc.Portfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Will Celularity Inc. outperform its industry peersWeekly Risk Summary & AI Powered Trade Plan Recommendations - خودرو بانک
Using AI based signals to follow Celularity Inc.Portfolio Value Report & Daily Technical Stock Forecast Reports - Newser
Can Celularity Inc. Equity Warrant continue delivering strong returnsQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - خودرو بانک
Will earnings trigger a reversal in Celularity Inc.July 2025 Snapshot & Safe Capital Allocation Plans - Newser
Can Celularity Inc. Equity Warrant scale operations efficiently2025 Support & Resistance & Reliable Intraday Trade Plans - خودرو بانک
Is a relief rally coming for Celularity Inc. Equity Warrant holdersWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
When is the best time to exit Celularity Inc. Equity WarrantJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
Chart based analysis of Celularity Inc. trendsWeekly Trend Report & Low Drawdown Investment Strategies - Newser
Momentum Indicator Shows Bearish Divergence in Celularity Inc.Weekly Stock Report & Capital Protection Trading Alerts - beatles.ru
Multi asset correlation models including Celularity Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser
What is the long term forecast for Celularity Inc. Equity Warrant stock2025 Investor Takeaways & Capital Protection Trading Alerts - خودرو بانک
Celularity Achieves Nasdaq Compliance with Recent Filing - The Globe and Mail
Published on: 2025-09-04 05:10:48 - Newser
Celularity Inc. Equity Warrant stock trend forecastTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
Real time scanner hits for Celularity Inc. explainedAnalyst Downgrade & Weekly High Momentum Picks - Newser
Celularity Fulfills Nasdaq Listing Rule, Retires $41.6mln Debt, and Unveils Growth Plans - AInvest
Is it time to cut losses on Celularity Inc. Equity WarrantShare Buyback & Daily Volume Surge Trade Alerts - Newser
Can machine learning forecast Celularity Inc. recoveryShort Setup & Capital Efficient Trade Techniques - Newser
Will Celularity Inc. Equity Warrant see short term momentumBuy Signal & Community Verified Trade Alerts - Newser
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celularity Inc-Aktie (CELU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):